Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1555

1.

Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.

Boyapati RK, Torres J, Palmela C, Parker CE, Silverberg OM, Upadhyaya SD, Nguyen TM, Colombel JF.

Cochrane Database Syst Rev. 2018 May 12;5:CD012540. doi: 10.1002/14651858.CD012540.pub2. Review.

PMID:
29756637
2.

High inter-individual variability of serum xanthine oxidoreductase activity in IBD patients.

Meijer B, Seinen ML, Hosman T, Linskens RK, Kneppelhout JK, Peters GJ, Mulder CJ, van Bodegraven AA, de Boer NK.

Nucleosides Nucleotides Nucleic Acids. 2018 May 3:1-7. doi: 10.1080/15257770.2018.1460477. [Epub ahead of print]

PMID:
29723116
3.

[Role of Rac1 signaling pathway of azathioprine and peptidoglycan in the regulation of monocyte-macrophage apoptosis in Crohn's disease].

Zhou Z, Jing Y, Ran Y, Zhao J, Zhou L, Wang BM.

Zhonghua Nei Ke Za Zhi. 2018 Apr 1;57(4):279-284. doi: 10.3760/cma.j.issn.0578-1426.2018.04.010. Chinese.

PMID:
29614587
4.

Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.

Holmstrøm RB, Mogensen DV, Brynskov J, Ainsworth MA, Nersting J, Schmiegelow K, Steenholdt C.

Dig Dis Sci. 2018 Jun;63(6):1583-1591. doi: 10.1007/s10620-018-5020-9. Epub 2018 Mar 21.

PMID:
29564674
5.

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease.

Vasudevan A, Beswick L, Friedman AB, Moltzen A, Haridy J, Raghunath A, Sparrow M, van Langenberg D.

Dig Liver Dis. 2018 Jul;50(7):682-688. doi: 10.1016/j.dld.2018.02.001. Epub 2018 Feb 10.

PMID:
29525182
6.

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database.

Kurti Z, Ilias A, Gonczi L, Vegh Z, Fadgyas-Freyler P, Korponay G, Golovics PA, Lovasz BD, Lakatos PL.

BMC Gastroenterol. 2018 Jan 30;18(1):23. doi: 10.1186/s12876-018-0746-6.

7.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.

Bermejo F, Aguas M, Chaparro M, Domènech E, Echarri A, García-Planella E, Guerra I, Gisbert JP, López-Sanromán A; en representación de GETECCU.

Gastroenterol Hepatol. 2018 Mar;41(3):205-221. doi: 10.1016/j.gastrohep.2017.11.007. Epub 2018 Jan 19. English, Spanish.

PMID:
29357999
8.

[X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].

Xu LJ, Luo YY, Yu JD, Lou JG, Fang YH, Chen J.

Zhonghua Er Ke Za Zhi. 2018 Jan 2;56(1):43-47. doi: 10.3760/cma.j.issn.0578-1310.2018.01.011. Review. Chinese.

PMID:
29342997
9.

Listeria Monocytogenes Brain Abscess in Crohn's Disease Treated with Adalimumab.

Atsawarungruangkit A, Dominguez F, Borda G, Mavrogiorgos N.

Case Rep Gastroenterol. 2017 Nov 9;11(3):667-671. doi: 10.1159/000481165. eCollection 2017 Sep-Dec.

10.

Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.

Wall GC, Muktar H, Effken C, Mahajan PB.

Pharmacotherapy. 2018 Feb;38(2):259-270. doi: 10.1002/phar.2067. Epub 2018 Jan 10. Review.

PMID:
29197117
11.
12.

Vulvar swelling as the first presentation of Crohn's disease in children-A report of three cases.

Ahad T, Riley A, Martindale E, von Bremen B, Owen C.

Pediatr Dermatol. 2018 Jan;35(1):e1-e4. doi: 10.1111/pde.13272. Epub 2017 Nov 21.

PMID:
29159956
13.

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.

Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T, Danalioglu A, Novacek G, Armuzzi A, Hébuterne X, Travis S, Danese S, Reinisch W, Sandborn WJ, Rutgeerts P, Hommes D, Schreiber S, Neimark E, Huang B, Zhou Q, Mendez P, Petersson J, Wallace K, Robinson AM, Thakkar RB, D'Haens G.

Lancet. 2018 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31. Erratum in: Lancet. 2018 Dec 23;390(10114):2768.

PMID:
29096949
14.

Cost-utility Analysis: Thiopurines Plus Endoscopy-guided Biological Step-up Therapy is the Optimal Management of Postoperative Crohn's Disease.

Candia R, Naimark D, Sander B, Nguyen GC.

Inflamm Bowel Dis. 2017 Nov;23(11):1930-1940. doi: 10.1097/MIB.0000000000001233.

PMID:
29019856
15.

Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.

Qiu Y, Chen BL, Feng R, Zhang SH, He Y, Zeng ZR, Ben-Horin S, Peyrin-Biroulet L, Mao R, Chen MH.

J Gastroenterol Hepatol. 2018 Mar;33(3):664-670. doi: 10.1111/jgh.14000.

PMID:
28940780
16.

Hypersensitivity to azathioprine in a patient with Crohn's disease: a case report.

Sousa M, Proença L, Carvalho J.

Rev Esp Enferm Dig. 2017 Oct;109(10):735. doi: 10.17235/reed.2017.5031/2017.

17.

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.

Allocca M, Landi R, Bonovas S, Fiorino G, Papa A, Spinelli A, Furfaro F, Peyrin-Biroulet L, Armuzzi A, Danese S.

Digestion. 2017;96(3):166-172. doi: 10.1159/000480231. Epub 2017 Sep 14.

PMID:
28903094
18.

Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.

Nakase H, Motoya S, Matsumoto T, Watanabe K, Hisamatsu T, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.

Aliment Pharmacol Ther. 2017 Nov;46(9):873-882. doi: 10.1111/apt.14318. Epub 2017 Sep 8.

19.

Crohn's Disease: Hard to Swallow!

Nandy N, Gavin M, Martin D, McCarthy D.

Dig Dis Sci. 2017 Oct;62(10):2690-2693. doi: 10.1007/s10620-017-4751-3. Epub 2017 Sep 7. No abstract available.

PMID:
28884257
20.

Postoperative prophylaxis in Crohn's disease after intestinal resection: a retrospective analysis.

O'Connor A, Hamlin PJ, Taylor J, Selinger C, Scott N, Ford AC.

Frontline Gastroenterol. 2017 Jul;8(3):203-209. doi: 10.1136/flgastro-2016-100749. Epub 2016 Dec 1.

Supplemental Content

Loading ...
Support Center